16August

Semaglutide superior to dulaglutide on glucose control and weight loss in people ... Read more

15August

Changes in Novo Nordisk Executive Management ... Read more

09August

Novo Nordisk increased reported operating profit by 8% in the first six months o ... Read more

27July

Novo Nordisk A/S: Victoza® has been approved in the EU as the only GLP-1 with a ... Read more

16August

Semaglutide superior to dulaglutide on glucose control and weight loss in people ... Read more

15August

Changes in Novo Nordisk Executive Management ... Read more

14August

Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more

14August

Novo Nordisk A/S - Share repurchase programme ... Read more

18August

Ex-dividend,

21August

Record date,

22August

Interim dividend payment, B shares,

23August

Deutsche Bank Scandinavian Corporate Days, Helsinki

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
ADA investor presentation 


ADA 2017 investor presentation and webcast

 
Q2 2017 financial results


Q2 2017 conference call and roadshow presentation



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.


LEADER AdCom